Literature DB >> 22358632

Acceptability of continuous cell lines for the production of biologicals.

J Löwer1.   

Abstract

Year:  1995        PMID: 22358632     DOI: 10.1007/BF00744315

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


× No keyword cloud information.
  7 in total

1.  Viral validation strategy for recombinant products derived from established animal cell lines.

Authors:  P J Shadle; P R McAllister; T M Smith; A S Lubiniecki
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

2.  EEC regulatory document. Note for guidance. Validation of virus removal and inactivation procedures. Committee for Proprietary Medicinal Products: Ad Hoc Working Party on Biotechnology/Pharmacy and Working Party on Safety Medicines.

Authors: 
Journal:  Biologicals       Date:  1991-07       Impact factor: 1.856

3.  Acceptability of cell substrates for production of biologicals. Report of a WHO Study Group on Biologicals.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1987

4.  Theoretical considerations on viral inactivation or elimination.

Authors:  H Willkommen; J Löwer
Journal:  Dev Biol Stand       Date:  1993

Review 5.  Cellular oncogenes and multistep carcinogenesis.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Science       Date:  1983-11-18       Impact factor: 47.728

6.  The acceptability of continuous cell lines: A personal & historical perspective.

Authors:  J C Petricciani
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

7.  Tumorigenic activity of polyoma virus and SV40 DNAs in newborn rodents.

Authors:  L Bouchard; C Gelinas; C Asselin; M Bastin
Journal:  Virology       Date:  1984-05       Impact factor: 3.616

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.